Stefani A. Wolff's Insider Trades & SAST Disclosures
Stefani A. Wolff's most recent trade in Nurix Therapeutics Inc was a trade of 962 Restricted Stock Units done . Disclosure was reported to the exchange on April 30, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Stefani A. Wolff.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nurix Therapeutics Inc | Stefani A. Wolff | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2023 | 962 | 10,582 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Stefani A. Wolff | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2023 | 962 | 6,455 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Stefani A. Wolff | EVP and COO | Sale of securities on an exchange or to another person at price $ 9.88 per share. | 30 Apr 2023 | 342 | 6,113 | - | 9.9 | 3,378 | Common Stock |
| Nurix Therapeutics Inc | Stefani A. Wolff | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 88,900 | 88,900 | - | - | Employee Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Stefani A. Wolff | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 24,000 | 24,000 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Stefani A. Wolff | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2023 | 962 | 11,544 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Stefani A. Wolff | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2023 | 962 | 4,364 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Stefani A. Wolff | EVP and COO | Sale of securities on an exchange or to another person at price $ 11.78 per share. | 30 Jan 2023 | 424 | 3,940 | - | 11.8 | 4,995 | Common Stock |
| Nurix Therapeutics Inc | Stefani A. Wolff | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2022 | 962 | 12,506 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Stefani A. Wolff | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2022 | 962 | 3,752 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Stefani A. Wolff | EVP and COO | Sale of securities on an exchange or to another person at price $ 12.88 per share. | 30 Oct 2022 | 350 | 3,402 | - | 12.9 | 4,508 | Common Stock |
| Nurix Therapeutics Inc | Stefani A. Wolff | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 110,375 | 110,375 | - | - | Employee Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Stefani A. Wolff | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2022 | 962 | 13,468 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Stefani A. Wolff | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2022 | 962 | 1,594 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Stefani A. Wolff | EVP and COO | Sale of securities on an exchange or to another person at price $ 15.67 per share. | 30 Jul 2022 | 356 | 1,238 | - | 15.7 | 5,579 | Common Stock |
| Rain Oncology Inc | Stefani A. Wolff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Nurix Therapeutics Inc | Stefani A. Wolff | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2022 | 962 | 962 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Stefani A. Wolff | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2022 | 962 | 14,430 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Stefani A. Wolff | EVP and COO | Sale of securities on an exchange or to another person at price $ 11.75 per share. | 30 Apr 2022 | 330 | 632 | - | 11.8 | 3,878 | Common Stock |
| Nurix Therapeutics Inc | Stefani A. Wolff | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 34,631 | 34,631 | - | - | Employee Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Stefani A. Wolff | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 15,392 | 15,392 | - | - | Restricted Stock Units | |
| Rain Oncology Inc | Stefani A. Wolff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges